Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF.

ESC Heart Fail · 2024 · PMC10804148 · PMID 38041517

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

persistent to sacubitril/valsartan treatment, although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.